Loading clinical trials...
Loading clinical trials...
This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 help...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT07516964 · Nephrotic Syndrome With Edema (Diagnosis), Minimal Change Nephrotic Syndrome, and more
NCT07219121 · Proteinuria, Immunoglobulin A (IgA) Nephropathy, and more
NCT06090227 · Focal Segmental Glomerulosclerosis
NCT05650619 · Focal Segmental Glomerulosclerosis, Minimal Change Disease, and more
NCT02235857 · Focal Segmental Glomerulosclerosis
Alabama Kidney Research
Alabaster, Alabama
Apogee Clinical Research
Huntsville, Alabama
Southwest Kidney Institute
Surprise, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions